Showing 1641-1650 of 2891 results for "".
- Pluri Launches Regenerative Aesthetics Subsidiary Cellav in Collaboration with Miss Universe Skincarehttps://modernaesthetics.com/news/pluri-launches-regenerative-aesthetics-subsidiary-cellav-in-collaboration-with-miss-universe-skincare/2484496/Pluri Inc. has launched Cellav Health and Aesthetics Ltd., focused on science-based regenerative skincare. The company announced a strategic collaboration with Miss Universe Skincare to co-develop a new line of cell-based skincare products.
- AAFPRS Forecasts Regeneration, Precision, and Personalization as Defining Aesthetic Trends for 2026https://modernaesthetics.com/news/aafprs-forecasts-regeneration-precision-and-personalization-as-defining-aesthetic-trends-for-2026/2484425/Aesthetic medicine is rapidly evolving beyond enhancement and rejuvenation, moving toward regenerative, precision-driven care tailored to the individual. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released its annual aesthetic trend forecast, highlighting the t
- FDA Clears Ultherapy PRIME for Skin Laxity on Arms, Abdomenhttps://modernaesthetics.com/news/fda-clears-ultherapy-prime-for-skin-laxity-on-arms-abdomen/2484325/The US Food and Drug Administration (FDA) has cleared Ultherapy PRIME for the treatment of skin laxity on the anterior arms, posterior arms, and abdomen, according to Merz Aesthetics. The device is now FDA-cleared for noninvasive lifting and firming of the face, neck, décolleté, and body.
- FDA Approves Restylane Lyft for Chin Augmentation in Adultshttps://modernaesthetics.com/news/fda-approves-restylane-lyft-for-chin-augmentation-in-adults/2484326/Galderma announced today that the U.S. Food and Drug Administration (FDA) has approved Restylane® Lyft™ with Lidocaine for chin augmentation in adults over 21 with mild-to-moderate chin retrusion.
- Facial Aesthetic Surgical Training May Lag Behind Market Demand, Study Findshttps://modernaesthetics.com/news/facial-aesthetic-surgical-training-may-lag-behind-market-demand-study-finds/2484290/A new analysis published in the Journal of Plastic, Reconstructive & Aesthetic Surgery suggests that US plastic surgery residency programs may not be fully aligned with procedural trends in the growing facial aesthetics market. The study compares Accreditation Council for Graduate Me
- InMode Appoints Michael Dennison as President of North Americahttps://modernaesthetics.com/news/inmode-appoints-michael-dennison-as-president-of-north-america/2484275/InMode Ltd has promoted Michael Dennison to president of North America, the company announced. Dennison previously served as vice president of sales. Dennison joined InMode nearly a decade ago and has held multiple leadership r
- Dermal Repair Complex Wins 2025 Nourish Award for Beauty and Collagen Supplementhttps://modernaesthetics.com/news/dermal-repair-complex-wins-2025-nourish-award-for-beauty-and-collagen-supplement/2484256/Beverly Hills MD Dermal Repair Complex has received the 2025 Nourish Award in the Beauty and Collagen category, according to a company announcement. The supplement, developed by cosmetic surgeons John Layke, DO, and Payman Danielpour, MD, is marketed as a skin-focused nutritional product formulat
- FDA Clears AVAVA Device for Wrinkle Treatment Across All Skin Typeshttps://modernaesthetics.com/news/fda-clears-avava-device-for-wrinkle-treatment-across-all-skin-types/2484238/AVAVA® has received US Food and Drug Administration (FDA) clearance for the treatment of fine lines and wrinkles across Fitzpatrick skin types I-VI, marking its second clearance in recent months following its prior approval for acne scars. The nonablative platform, powered by Focal Point T
- CollPlant Launches US Logistics Hub to Support North American Growthhttps://modernaesthetics.com/news/collplant-launches-us-logistics-hub-to-support-north-american-growth/2484120/CollPlant Biotechnologies has expanded its North American operations through a new partnership with a US-based logistics hub, the company announced. The center, expected to become operational this quarter, will support the growing distribution needs for CollPlant’s recombinant human collagen (rhC
- AAFPRS Highlights Energy-Based Device Trends Defining Aesthetic Advancements in 2025https://modernaesthetics.com/news/aafprs-highlights-energy-based-device-trends-defining-aesthetic-advancements-in-2025/2484060/The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) is spotlighting the latest innovations in energy-based devices (EBDs), signaling a shift toward increasingly personalized, nonsurgical facial rejuvenation in 2025.